Birmingham's University Hospitals NHS Foundation Trust and Queen Elizabeth Hospital manage significant multiple myeloma patient populations requiring Lenalidomide-based regimens. Lenalid 25mg now makes this essential treatment dramatically more affordable following patent expiry, without compromising clinical quality.
Lenalid is an immunomodulatory drug (IMiD) that stimulates immune attack on myeloma cells while inhibiting tumour blood vessel formation. It's used in combination with dexamethasone for relapsed and refractory disease, and as maintenance therapy after stem cell transplant — where clinical trials showed it significantly extended progression-free survival compared to placebo.
Brand Revlimid costs over £4,000 monthly in the UK private market. Generic Lenalid from WHO-GMP certified Indian manufacturers provides identical efficacy at savings of thousands of pounds monthly — vital for Birmingham patients self-funding or supplementing NHS supply. Visit medshopy.com or WhatsApp +91 82650 41513.
Lenalid is an immunomodulatory drug (IMiD) that stimulates immune attack on myeloma cells while inhibiting tumour blood vessel formation. It's used in combination with dexamethasone for relapsed and refractory disease, and as maintenance therapy after stem cell transplant — where clinical trials showed it significantly extended progression-free survival compared to placebo.
Brand Revlimid costs over £4,000 monthly in the UK private market. Generic Lenalid from WHO-GMP certified Indian manufacturers provides identical efficacy at savings of thousands of pounds monthly — vital for Birmingham patients self-funding or supplementing NHS supply. Visit medshopy.com or WhatsApp +91 82650 41513.